In this study, using multi‐centre cohorts with methylation and gene expression data, we carried out an integrative study to explore the prognostic role of BTG2 in early‐stage (clinical stage I, II) NSCLC. The gene discussed is BTG2; the disease is non-small cell lung carcinoma.